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A b s t r a c t  
Different stereoisomers ofthe cytotoxic 5-fluorouracil (5FU)homodimers were synthesizedby 
photochemical [2+2]-cycloaddition and polymerized into MMA/HEMA to form a novel drug-loaded 
copolymer for intraocular lenses as irradiation-activated treatment for secondary cataract. Three 
isomers were obtained, and showed significant differences in cleavage efficiency on photo-cleavage 
via single-photon-absorption (SPA)and two-photon-absorption (TPA). The most efficient TPA 
cleavage rate was observed for the syn-head-to-head 5FU dimer, which was, consequently, used for 
drug loading of the polymeric material to obtain a drug-loaded material of higher efficiency compared 
to previous works. The light and thermal stability of the polymer were confirmed and multi-dose 
release of the drug in aqueous solution for possible repeated treatment of cataract was proven. 
Keywords: Photo-triggered drug release, 5-fluorouracil, isomers, two-photon-absorption, 
[2+2]-cycloreversion, acrylic polymer. 
Introduction 
Cataract is a disease caused by a dysfunction of eye 
metabolism,leading to an opacification of the natural lens.[1,2] 
About 20 million people worldwide have lost their vision due to 
cataract.[3,4]The standard treatment is the extracapsular cataract 
extraction (ECCE), i.e. the implantation of a posterior-chamber 
intraocular lens (IOL).[5,6] The most frequent complication 
associated with this treatment is the posterior capsule opacification 
(PCO) occurring in 15% to 50% of cases within three to five years 
after lens replacement.[7,8,9,10] The common treatment of PCO is 
laser capsulotomy,[11]which leads to thermal destruction of the 
posterior capsular bag.[12]Typical complications are retinal 
detachment and macular edema.[13]Several experiments using 
drugs such as colchicine, methotrexate, retinoic acid and 
5-fluorouracil (5FU) have been made in animal models for PCO 
treatment with 5FU emerging as one of the most effective cytotoxic 
drugs.[14,15,16,17,18,19,20] 
The pathogenesis of PCO is attributed to the persistence and 
response of lens epithelial cells (LECs). A fibrotic type of PCO 
appearsaccompanied by a capsular bag contraction. This depends 
on the proliferation and fibrous metaplasia of interior and equatorial 
LECs.[21,22] 
In this work, we present a photochemically controlled drug release 
system for 5FU from 5FU homodimers formed by a Woodward-
Hoffman [2+2]-cycloaddition reaction linking two molecules of the 
5FU cytotoxic drug.To facilitate the reaction, a heptanoyl residue is 
temporarily attached to the 5FU molecule. Three out of four 
theoretically possible isomers were obtained in the photosynthesis 
(Figure. 1). The single-side deprotected homodimer with the 
highest two-photon-absorption photocleavage rate, i.e. the syn-hh-
HD, is attached to the polymer backbone.  
The formed polymer fulfills all the material demands for the 
manufacture of hydrophilic IOLs. During polymer hydration, the 
remaining heptanoyl group is hydrolyzed by adding phosphoric 
acid. The polymer is ready for use after solution is exchanged and 
brought to neutrality.  
The 5FU dimer may be cleaved by light in a [2+2]-cycloreversion 
reactionwith wavelengths below 300 nm via single-photon-
absorption (SPA) or with light in the visible range, e.g. 532 nm, via 
two-photon-absorption (TPA), the key to drug release from an 
implanted IOL. The released drug diffuses out of the IOL into the 
capsular bag to cause apoptosis of the LECs and treat PCO.  
Compared to prior work from, e.g. Härtner et al. who used 
heptanoyl-modified 5FU dimers matrix-embedded into a 
hydrophobic polymer, the 5FU dimers from the new polymer do not 
show any leakage from the polymer without photo excitation. In 
addition, only 5FU, and no auxiliary compound, is released 
because the heptanoyl residue is cleaved off the hydrophilic 
polymer during swelling. Finally, the new polymer may be steam 
autoclaved, which is the most simple and common sterilization 
method. In other work[23,25] coumarin was used as a linker 
molecule to attach the 5FU to the polymer backbone. The problem 
with coumarin is that the lactone ring may be opened by pH 
changes or thermal treatment, which changes the photochemical 
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Figure 1. Synthesis of the drug release polymer. In the dimerization of (3) three out of four possible stereoisomers are 
obtained, syn-head-to-head-HD (4), syn-head-to-tail-HD (5), and anti-head-to-head-HD (6). After single side deprotection of 
(4) methyl-methacrylate (MMA) is attached to (7a) which is copolymerized with MMA/HEMA to form (9). After acid catalyzed 
hydrolysis of the remained heptanoyl group the final polymer (10) is obtained. 
 
The Âdual-useÊ of 5FU as linker as well as drug to be released 
solves both problems and brings these materials closer to 
application.  
Materials and Methods 
Materials 
All materials were purchased from Acros Scientific,Air Liquide, 
Fluorochem (TBDMS-Cl), Melrob, Sigma Aldrich 
(heptanoylchloride, EDC, DMAP)and were used as received.  
Photochemical syntheses 
For the photochemical synthesis of homodimers an UV-reactor was 
used which was equipped with 12 fluorescent tubes(40W-R/35, 
Bodytone, Isolde). All reactions were carried out under Schlenk-
conditions with argon as protective gas. 
Analytics 
The reactions were characterized by NMR recorded on a Bruker 
DRX-500 FT-NMR (500 MHz, 1H-NMR, NOESY, COSY, HMBC) 
andon a Bruker,Advance 300 spectrometer (75 MHz 13C-NMR).  
Analytical RP-HPLC measurements were done on an Ultimate 
3000 system from Dionex, equipped with a Nucleosil column 
(Prontosil RP-C18, 5.0 øm, 250 ï 4mm, Bischoff Chromatography), 
a quaternary low pressure gradient pump, a column oven, and a 
diode array detector(DAD). The eluent for isocratic separation was 
a 75:25 mixture of acetonitrile:water (ultra-pure water 0.065øScm-1 
from TKA ultra-pure water purification system) which was acidified 
with 300øl L-1concentrated H3PO4.  
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The isomeric products were purified by a preparative RP-HPLC 
system consisting of a P680 HPLC pump, an AD 25 absorbance 
detector (bothfrom Dionex), and a YMC-Pack ODS-A column, 250 
mmï 30mm, 5øm.Isocratic purifications were done with 70:30 
acetonitrile:water with 10øl H3PO4 conc. added per liter.  
LC/MS analysis was done on an ESI/MS LCQ DUO mass 
spectrometer (Thermoelectron) with a Nucleosil 100-3-C18 column 
(3øm, 250 ï 4mm) from Bischoff Chromatography, Germany. 
UV/Visspectra were recorded on a Lambda 35 spectrometer from 
Perkin Elmer in the range of 190 nm to 800 nm in steps of 1 nm. 
Measurements were done in quartz cuvettes (QS, Hellma; UQ, 
Portman Instruments) with 10 mm path length. 
Sterilization of the polymers was done in an autoclave at 121ĈC 
and 2 bar (2540 EL, Tuttnauer). 
Single-photon-absorption (SPA) induced cycloreversion 
The photochemical cycloreversion of homodimers in solution and 
polymers was achieved by irradiation with wavelengths of 266 nm 
in acetonitrile. 2.0 ml of a 0.21 mmol l-1 solution of isolated isomer 
were irradiated with an UV266 LED (UV-LUX260) having an energy 
of 5.1ൈ10-4 W/cm2 (number of photons per second: 6.80 ï1014) at 
room temperature.The intensity of the diode as well as the light 
transmitted through the sample was measured by a photodiode 
from Hamamatsu (Modell: S133BQ1010) combined with a Keithley 
485 Autoranging Picometer. 
Two-photon-absorption (TPA) induced cycloreversion 
TPA measurements were made with 2.7 ml of 2.1mmol l-1 stirred 
solutions in acetonitrile of individual homodimersand of polymers at 
room temperature under irradiation with a 532 nm pulsed Nd:YAG 
laser (Infinity 40-100, Coherent) with a pulse length of 3 ns. The 
laser beam had a diameter of 5.5 mm with a flat-top profile and a 
repetition rate of 40 Hz. The average energy was measured using 
a Fieldmaster GS power meter equipped with a 80V detector head 
(both Coherent).The photo-cleavage progress was traced 
photometrically by measuring the absorbance change at 266 nm. 
Synthetic procedures 
Synthesis of 1-heptanoyl-5-fluorouracil (H5FU) 
5FU ishardly soluble in most organic solvents. A heptanoyl group 
was attached as protection groupand to improve solubility. The 
unprotected amino group of 5FU interferes with the photochemical 
reaction and reduces the yield. The reaction was done as 
described earlier.[28] 
1H-NMR (300 MHz, DMSO-d6): Ē/ppm= 7.25 (s, 1H), 7.07 (s, 1H), 
2.60-2.56 (m, 2H), 2.69-1.61 (m, 2H), 1.42-1.29 (m, 6H), 1.01-0.97 
(t, J= 6.6 Hz, 3H). 13C NMR result (75MHz, DMSO-d6): Ē/ppm= 
177.04, 157.39, 150.43, 138.70, 115.82, 37.53, 31.65, 29.74, 
22.50, 22.94, 14.02. LC/MS (ESI): m/z calc. 242.12 g/mol, found 
242.23 g/mol (M+). 
Preparation of 1-heptanoyl-5-fluorouracil-homodimers 
(H5FU-HD) 
The dimerization of H5FU (3)was done in a Rayonett type 
photoreactor with wavelengths above 300 nm. In each test tube 1.0 
g H5FU (3,0.004128 mol) was dispersed in 15 ml 
chloroformwith3.0 mg photosensitizer benzophenone (0.0165 
mmol) added.The white suspension was degassed for 10 min with 
argon and thenirradiated with UV light for 48-72 h. The reaction 
progress was monitored by HPLC. The reaction was stopped as 
soon as no further dimer formation was observed. The tubes were 
combined, evaporated and dried. The crude product wasdissolved 
in acetonitrile, filtered and purified viaisocratic preparative HPLC. 
The homodimerswere received as white solids(H5FU-HD isomer 4: 
0.34 g, 0.70 mmol, 34 %; isomer 5:0.28 g, 0.58 mmol, 28 %; 
isomer6:0.18 g, 0.32 mmol, 17.5%). Stereochemistry was 
determined from 2D NMR: COSY, NOESY, and HMBC (for details 
see supporting information). 
NMR data of syn-hh-HD isomer (4):1H NMR (300 MHz, DMSO-d6): 
Ē/ppm= 11.69 (s, 2H), 5.39 ă 5.33 (m, 2H), 3.01 ă 2.94 (m, 2H), 
2.85 (ddd, J = 17.1, 8.2, 6.5 Hz, 2H), 1.61 ă 1.54 (m, 4H), 1.29 (dd, 
J = 5.9, 4.1 Hz, 12H), 0.88 (s, J = 6.7 Hz, 6H).13C NMR: (75MHz, 
DMSO-d6): Ē/ppm= 174.05, 162.84, 149.54, 57.36, 37.73 31.02 
28.03 24.13 21.96 13.87. 19F NMR (282MHz, DMSO-d6): Ē/ppm= -
171.39, -151.38. 
LC/MS (ESI): m/z 484.21 g/mol (calc.), found 484.2 g/mol (M+). 
NMR dataofsyn-ht-HD isomer (5):1H NMR (300 MHz, DMSO-d6): 
Ē/ppm= 11.81 (s, 2H), 5.99 ă 5.85 (m, 2H), 2.96 ă 2.88 (m, 2H), 
2.82 (m, 2H), 1.66 ă 1.50 (m, 4H), 1.37 ă 1.22 (m, 12H), 0.86 (d, J 
= 7.0 Hz, 6H).13C NMR(75MHz, DMSO-d6): Ē/ppm= 173.95, 
161.94, 148.50, 56.06, 37.82, 31.02, 28.09, 24.06, 21.96, 
13.88.19F NMR (282MHz, DMSO-d6): Ē/ppm= -204.81, -188.41.  
LC/MS (ESI): m/z 484.21 g/mol (calc.), found484.21 g/mol (M+). 
NMR data of anti-hh-HD isomer (6):1H NMR:(300 MHz, DMSO-d6): 
Ē/ppm= 11.86 (s, 2H), 5.55 ă 5.49 (m, 2H), 2.75 (t, J = 7.3 Hz, 4H), 
1.50 (dd, J = 13.9, 6.7 Hz, 4H), 1.32 ă 1.23 (m, 12H), 0.88 (dd, J = 
7.0, 4.7 Hz, 6H).13C NMR (75MHz, DMSO-d6): Ē/ppm= 173.75, 
161.98 150.10 53.77 53.53 38.13 28.57 24.51 22.43 14.32.19F 
NMR (282MHz, DMSO-d6): Ē/ppm= -151.95, -157.86. 
LC/MS (ESI): m/z 484.21 g/mol (calc.), found 484.1 g/mol (M+). 
Deprotection of H5FU homodimers 
The heptanoyl protection group of the homodimer (4)(154.9 mg, 
0.32 mol) was partially removed under mild conditions by stirring 
the product in a methanol/water mixture (60/40;200ml) for 96 h at 
55ĈC. The progress of the reaction was monitored by HPLC. The 
reaction was stoppedby cooling. The double-deprotected product 
(7b) precipitates and was removed by filtration.The crude product 
was purified via isocratic preparative HPLC. The eluent was 
evaporated, the material dissolved in methanol and crystallized. 
The single-sidedeprotected homodimer(7a) as main product was 
obtained as a white solid (68 mg, 0.14 mmol, 44 %). 
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LC/MS (ESI): m/z calc. single deprotected: 372.12g/mol (M+), 
found 371.1 g/mol; double deprotected:260.0 g/mol (M+), found 
263.1 g/mol. 
Attachment of methyl-methacrylate to single-side 
deprotected syn-hh-H5FU-HD 
For covalent immobilization of the dimer, methyl-methacrylate was 
covalently bound to the deprotected amino group of syn-hh-HD 
(7).60 mg homodimer (0.12 mmol), 40.38 mg ethyl-(NÊ,NÊ-
dimethylamino)propylcarbodiimide hydrochloride (EDC, 1.7 eq, 
0.21 mmol) and 3.03 mg 4-(N,N-dimethylamino)pyridine (DMAP, 
0.2 eq., 0.025 mmol) were dissolved in dry dichloromethane (50ml) 
at 0ĈC under argon atmosphere. 11.50øl methacrylic acid (1.1 eq., 
0.14mmol) were slowly added under Schlenk conditions and stirred 
for 24-48 h.The progress was monitoredvia HPLC. The crude 
product was extracted with 5% NaHCO3 and brine. The organic 
phase was evaporated, dried in vacuo. Ayield of88 mg (84%) of a 
slightly brown solid was received. The product was analyzed via 
NMR and LC/MS. 
NMR data of syn-hh-HD-MMA(8):1H NMR (300 MHz, DMSO-
d6):Ē/ppm= 8.39 (s, 1H), 8.07 (s, 1 H), 6.77 (m, 1H), 5.24-5.21 (m, 
1H), 4.99-4.97 (t, J = 0.40 Hz, 2H), 4.84 (m, 2H), 2.85 (s, 1 H), 1.88 
(t, J = 7.0, 4.7 Hz, 3H).13C NMR (75MHz, DMSO-d6): 
Ē/ppm=174.08, 164.21, 163.97, 163.07, 162.76, 151.32, 151.13, 
149.94, 124.94, 85.50, 81.89, 57.92, 56.35, 56.03, 31.07, 28.06, 
24.22, 21.99, 13.92. 19F NMR result (282MHz, DMSO-d6): Ē/ppm= 
-179.3.  
LC/MS calculated 328.06 g/mol (M+), found 329.5 g/mol. 
 
Photochemical co-polymerization of syn-hh-5FU-HD-
MMAwith HEMA/MMA  
65 mg of syn-hh-5FU-HD-MMA(0.2 mmol) (8)were dissolved in 2.6 
g of a standard 20:80 MMA:HEMA mixture with ethylene-glycol-
dimethacrylate (EGDMA) as crosslinker and campherquinone and 
ethyl-4-dimethylaminobenzoate as photostarters.[24,27] The 
polymer mixture was degassed and filled into the polymerization 
form (3.6ï3.6ï0.25 cm). The polymerization was started by 
irradiation with 470 nm light. An optically transparent plate, 
containing 2.5 w/w% of drug loaded monomer was obtained. A 
second series of samples was preparedcontaining 1 % of the UV-
absorber 2(4-benzoyl-3-hydroxy-phenoxy)ethyl-acrylate (BHP-EA) 
in addition. 
Polymer sample preparation 
The polymer was cut into round blanks of 8 mm diameter and 0.25 
mm thickness by a CO2-Laser (Skylaser 9060-80, 80 W CO2-Laser 
4-10.6 øm, Pfeiffer). 
Hydration of polymer 
The samples were incubated for 21 days at room temperature 
inwater for hydration and for ensuring that the photo starter 
completely diffused out of the polymer topreventany interferences 
of the absorption of the starter with the released drug during 
UV/Vis spectroscopy. To ensure that the heptanoyl group was 
detached the water was acidified with0.1 % H3PO4. UV/Vis spectra 
of the incubation solution were taken regularly. No drug diffused 
out of the polymerduring hydration.  
Results and Discussion 
The photochemical synthesis of dimers produced three of four 
possible isomers. For the drug release, the dimers areto be 
cleaved photochemically. The different isomers show quite different 
photochemical efficacies for [2+2]-cycloreversion triggered by SPA 
as well as TPA. In cases where the mixture of isomers is used in 
the drug release polymer, first the more light sensitive dimers are 
cleaved and then the less sensitive ones. This means, the amount 
of drug released per light dose changes constantly. To circumvent 
this, we prepared the drug release polymer with one isolated 
isomer only, having the highest cleavage efficiency under TPA 
conditions.  
SPA-induced cycloreversion of the H5FU-HD isomers 
The syn-hh-HD, syn-ht-HD and anti-hh-HD homodimers from 
H5FU were photosynthesized in a Rayonett reactor and purified by 
preparative HPLC (see Figure. 1). The anti-ht-HD was not 
observed. Their stereochemistry was determined by NMR 
spectroscopy.[28] All the H5FU dimers are less soluble in polar 
solvents like water than the monomers. Irradiation of the 
homodimers with 266 nm in acetonitrile causes the cycloreversion 
of the homodimers (Figure. 2). 
 
Figure 2.Photocleavage of H5FU homodimers. The photocleavage (hν) may be accomplished either by single-photon-
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absorption in deep UV or by two-photon-absorption with wavelengths in the visible.
As the HPLC analysis tracing the SPA-induced cycloreversion of 
the homodimers uses acidified water in the eluent, both H5FU and 
5FU are observed because the heptanoyl group is easily 
hydrolyzed.The difference spectra in Figure 3a show the time-
dependent and energy-dose-dependent increase in the 
absorbance at 260 nm, the maximal absorbance of H5FU.The 
dimers merely have any absorbance at 260 nm, so the absorbance 
is characteristic of the H5FU (see supporting information S1). 
The photocleavageefficiency is characterized by the single photon 
quantum yield ĐSPAwhich is defined as the ratio of the number of 
dimer molecules nmolcleaved to the number of photonsnphot 
absorbed[26] with Eabs the absorbedenergy, λ the wavelength, chv 
the speed of light, h Planck's constant, Δc/Δt the slope of the time-
dependent concentration change of H5FU, V the volume of the test 
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The number of cleaved dimer molecules was calculated from the 
initial reaction rate v0 which was obtained from the linear fit of the 
concentration as a function of time (Figure.3b).  
The concentration changes, the initial reaction rate v0and the 
quantum yield of the isomer cleavage ĐSPA are summarized in 
Table 1. H5FU syn-hh-HD ĐSPA shows the highest quantum yield, 
followed by H5FU syn-ht-HD and H5FU anti-hh-HD. It should be 
mentioned that the absorption of the dimers at 266 nm is quite low 
(for reference see supporting information Figure S1) but we have 
chosen this wavelength because the two-photon-absorption 
induced cycloreversion is done at 532 nm. 
As already known from other dimers,[29,30] the configuration 
influences activation barrier for cycloreversion. Both hh dimers 
show significantly better SPA quantum yields than the ht isomer.  
TPA-induced cycloreversion of the H5FU-HD isomers 
Solutions of the homodimers(4), (5), and (6)in acetonitrile (c=0.21 
mmol/L) were irradiated with intense 532 nm pulses (40 Hz, 3 ns) 
which cause TPA-induced cleavage of the homodimer (Figure.4a). 
The cleavage is monitored at 266 nm. An increase of the 
absorption at this wavelength proves the cleavage of the 
cyclobutane ring of the homodimer. The TPA cross section was 
measured at fourdifferent energies (90 mJ, 100 mJ, 110 mJ, 120 
mJ) (Figure.4b). The rising concentration of released H5FU was 
plotted against the irradiation time for different pulse energies to 
obtain the initial reaction rate v0. In Figure 4c the double 
logarithmic plot of the initial reaction rate v0as a function of the 
pulse energies P is presented. A linear slope of 2.23 results, which 
confirms generally the two-photon nature of the cycloreversion. 
The results for all three isomers are summarized in Table 2. Again 
the hh isomers are more efficient than the ht isomers, but 
compared to SPA the difference between syn-hh and anti-hh is 
more significant. 
 
Figure 3. (a) Difference spectra of syn-hh-HD in solution taken after different doses of irradiation. An increase in absorbance change ind
free 5FU. (b) SPA quantum yield (ĐSPA) determination for all three isolated stereoisomers. 
 
Table 1.Molar extinction coefficients and photochemical cleavage parameters of H5FU homodimers via SPA. 








H5FU 6,279.07 μ 43.04  
syn-hh-HD 346.58 μ 31.05 8.92  10 -9 8.42  1012 2.76 
syn-ht-HD 163.97 μ 4.45 4.96ï10 -10 0.99  1012 0.98 
anti-hh-HD 178.42 μ 11.62 6.99  10 -9 7.06  1012 1.74 
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Figure 4. Two-photon-absorption induced cleavage of syn-hh-HD (4) in solution. (a) UV/Vis difference spectra accompanying the irradiation with 
Nd:YAG laser as a function of irradiation energy. (b) Released H5FU at different pulse intensities (40Hz and 3 ns pulse length). (c) Double 
logarithmic plot of the applied laser intensities P versus the initial rate vo (slope 2.23). (d) Scheme of the photocleavage reaction of homodimer. 
  Table 2.Photochemical cleavage parameters of H5FU homodimers via TPA 
Stereoisomer pulse energy v0 average  Ē 
  (mJ) mol/L GM GM 
syn-hh 90 9.09 ï 10-5 0.52 0.58 
  110 1.34 ï 10-4 0.59  
 118 1.58 ï 10-4 0.57  
  130 2.00 ï 10-4 0.63  
syn-ht 98.5 4.94 ï 10-5 0.18 0.17 
  110 6.19 ï 10-5 0.18  
 118 6.49 ï 10-5 0.18  
  131 7.73 ï 10-5 0.16  
anti-hh 92.5 7.98 ï 10-5 0.23 0.25 
  110 1.10 ï 10-4 0.26  
 120 1.54 ï 10-4 0.27  
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SPA-and TPA-induced drug release from polymer  
Relevant for the application is the drug release from the hydrated 
polymer. Both SPA and TPA induce the release of 5FU (Figure. 5). 
Because there is an UV absorber in the polymer, the SPA induced 
cleavage is much less efficient, because most of the light is 
absorbed by the UV absorber and not by the dimers. 
 
 
Figure 5. SPA and TPA cleavage of the 5FU homodimers leaves one 5FU at the polymer and one 5FU molecule released
 
For SPA-induced drug release polymer blanks were irradiated with 
an UV LED for 2 min (Figure. 6a)in physiological salt solution (0.9 
% NaCl).The drug diffusion from the polymer into the solution was 
monitored via UV/Vis until equilibrium was reached. This procedure 
was then repeated. The drug release rate from the polymer was 
determined to be 1.1ï 10-4øg s-1 and the total drug release after 60 
min was 0.48øg. 
For analysis of TPA-induced drug release ahydrated polymer blank 
(1ï0.6ï 0.25 cm) was mounted in a home-made holder inside a 
quartz cuvette and irradiated with 532 nm pulses. UV/Vis spectra 
were taken to monitor the 5FU release out of the polymer. The 
irradiation of the polymer was repeated three times. In total 4.38 øg 
5FU were released (Figure. 6b). HPLC analysis (Figure. S7) shows 
that only 5FU is released. 
The released doses are more than adequate for cataract treatment 
to cause the inhibition and cell death of LECs.[17,31] This 
experiment demonstrates that a multidose drug release is possible 
meaning that repeated secondary cataract treatment is possible. 
Conclusions 
The cleavage of the three different homodimers of the cytotoxic 
drug analogue H5FU yielded a stereoisomer-dependent 
cycloreversion efficiency of SPA and TPA activation. Both head-to-
headconfigurations show a significantly greater cleavage efficiency 
compared to the head-to-tail configuration due to sterical effects of 
activation by the photons, and the highest efficiency was found for 
the syn-head-to-head dimer. The most efficient isomer should be 
used as drug carrier, as it is easy to obtain a drug-loaded polymer 
for secondary cataract treatment that may be activated with the 
lowest possible energy dose in the eye. The light fastness and the 
stability against autoclaving, the possible multi-dose release of 
drug from the polymer loaded with the high-efficiency isomer, and 
the release of a sufficient 5FU concentrations in aqueous solutions 
for removing the epithelial cells in the capsular bag during 
secondary cataractwas experimentally proven.[32]The system is 
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Supporting information  
Preparative isolation of H5FU-HD isomers 
2D-NMR of H5FU-HD isomers 
Thermal stability of polymer - Steam pressure sterilization  
Analysis of photo-triggered released compounds 
 
Preparative isolation of H5FU-HD isomers 
The isomeric were separated and purified on a preparative RP-HPLC 
(P680 HPLC pump, AD25 absorbance detector, both Dionex) 
equipped with a YMC-Pack ODS-A column (250 mm ï 30 mm, 5 øm). 
Isocratic elution with 70:30 acetonitrile:water with 10øl H3PO4 conc. 
added per liter.  
 
 
Figure S1: (a) Isolation of 5FU-isomers via preparative isocratic HPLC. Retention time of syn-hh-HD 4.34 min; syn-ht-HD 5.4 
min; anti-hh-HD 6.23 min. (b) Absorption spectra of H5FU at 0.018 mmol/L and the homodimers at 0.021 mmol/L in 
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Figure S4: 2D-NMR of anti-hh-H5FU-HD for conformational assignment.(a) Structural formula, (b) HMBC, (c) COSY,(d) 
NOESY. 
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Thermal stability of polymer - steam pressure sterilization  
Steam pressure sterilization of the hydrated polymers in 0.9% NaCl solution was done in glass vials in an autoclave at 121ĈC 
at 2 bar pressure (2540 EL, Tuttnauer). 
 
 
Figure S5: Sterilization of polymer samples at 121ĈC and 2 bar. HPLC chromatogram of the surrounding water solution after 
autoclaving process. (a) Chromatogram shows syn-hh-5FU-HD polymer, photochemical copolymerized, and (b) shows 5FU-
HD matrix-embedded into polymer.  
 
From the polymers only the two photostarter molecules as well as some non-polymerized UV-absorber is found in the 
solution (Fig. S5a). For means of comparison a polymer where the 5FU homodimer was just embedded into the polymer and 
not attached to the polymer moiety was co-analyzed. In this case free 5FU homodimer is observed in the sterilization solution 
as well as some UV-absorber. 
Analysis of photo-triggered released compounds 
 
It was analysed by HPLC whether only 5FU was released upon photochemical excitation or any other compounds or debris. 
Only 5-FU was observed for SPA as well as TPA. 
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Figure S7.HPLC chromatograms of the drug release by consecutive TPA irradiations(Fig. 6b) with 532 nm pulsed laser. 
No other products except 5FU are released. 
 
 
 
 
